A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design

References

• Aghazadeh-Habashi A, Jamali F. Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: Influence of gastrointestinal dysfunction on the relative bioavailability of two formulations. Eur J Pharm Biopharm 2008;70:889–894.
   PubMedGoogle Scholar
• Pairet M, van Ryn J, Schierok H, Mauz A, Trummlitz G, Engelhardt G. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4′-isomer. Inflamm Res 1998;47:270–276.
   PubMed Web of Science ®Google Scholar
• Distel M. Meloxicam clinical data on a preferential cyclooxygenase-2 inhibitor. J Clin Rheumatol 1998;4:s32–39.
   PubMedGoogle Scholar
• Distel M, Mueller C, Bluhmki E, Fries J. Safety of meloxicam: A global analysis of clinical trials. Br J Rheumatol 1996;35( Suppl. 1):68–77.
   PubMedGoogle Scholar
• Nalluri BN, Chowdary KP, Murthy KV, Becket G, Crooks PA. Tablet formulation studies on nimesulide and meloxicam-cyclodextrin binary systems. AAPS Pharm Sci Tech 2007;8:Article 36.
   Google Scholar
• Tacca MD, Colucci R, Fornai M, Blandizzi C. Efficacy and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug. Clin Drug Invest 2002;22:799–818.
   Google Scholar
• Han HK, Choi HK. Improved absorption of meloxicam via salt formation with ethanolamines. Eur J Pharm Biopharm 2007;65:99–103.
   PubMed Web of Science ®Google Scholar
• Goel H, Vora N, Rana V. A novel approach to optimize and formulate fast disintegrating tablets for nausea and vomiting. AAPS Pharm Sci Tech 2008;9:774–781.
   PubMed Web of Science ®Google Scholar
• Chandrasekhar R, Hassan Z, Alhusban F, Smith AM, Mohammed AR. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets. Eur J Pharm Biopharm 2009;72:119–129.
   PubMed Web of Science ®Google Scholar
• Bandari S, Mittapalli Rj Gannu, R, Rao YM. Orodispersible tablets: An overview. Asian J Pharma 2008;2:2–11.
   Google Scholar
• Ahmed IS, Fatahalla FA.Pilot study of relative bioavailability of two oral formulations of ketoprofen 25 mg in healthy subjects. A fast-dissolving lyophilized tablet as compared to immediate release tablet. Drug Dev Ind Pharm 2007;33:505–511.
   PubMed Web of Science ®Google Scholar
• Shoukri RA, Ahmed IS, Shamma RN. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm 2009;73:162–171.
   PubMed Web of Science ®Google Scholar
• van Schaick EA, Lechat P, Remmerie BM, Ko G, Lasseter KC, Mannaert E. Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers. Clin Ther 2003;25:1687–1699.
   PubMed Web of Science ®Google Scholar
• Liu YM, Liu GY, Liu Y, Li SJ, Jia JY, Zhang MQ, et al. Pharmacokinetic and bioequivalence comparison between orally disintegrating and conventional tablet formulations of flurbiprofen: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male volunteers. Clin Ther 2009;31:1787–1795.
   PubMed Web of Science ®Google Scholar
• Chen L, Jiang X, Huang L, Lan K, Wang H, Hu L, et al. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: A randomized sequence, open-label, two-way crossover study. Clin Ther 2009;31:2242–2248.
   PubMed Web of Science ®Google Scholar
• Singh R, Madan J. Optimization of mouth dissolving meloxicam tablets prepared by sublimation technique. Drug Invention Today 2009;1:146–149.
   Google Scholar
• Swamy PV, Areefulla SH, Shirsand SB, Granda S, Prashanti B. Orodipersible tablet of meloxicam using disintegrant blends for improved efficacy. Indian J Pharm Sci 2007;69:836–840.
   Google Scholar
• Lipka E, Amidon GL. Setting bioequivalence requirements for drug development based on preclinical data: Optimizing oral drug delivery systems. J Control Release 1999;62:41–49.
   PubMed Web of Science ®Google Scholar
• Ambrus R, Kocbek P, Kristl J, Sibanc R, Rajko R, Szabo-Revesz P. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam. Int J Pharm 2009;381:153–159.
   PubMed Web of Science ®Google Scholar
• Vijaya Kumar SG, Mishra DN. Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000. Yakugaku Zasshi 2006;126:657–664.
   PubMed Web of Science ®Google Scholar
• Pathak D, Dahiya S, Pathak K. Solid dispersion of meloxicam: Factorially designed dosage form for geriatric population. Acta Pharm 2008;58:99–110.
   PubMed Web of Science ®Google Scholar
• Ghareeb MM, Abdulrasool AA, Hussein AA, Noordin MI. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS Pharm Sci Tech 2009;10:1206–1215.
   PubMed Web of Science ®Google Scholar
• Nassab PR, Rajko R, Szabo-Revesz P. Physicochemical characterization of meloxicam-mannitol binary systems. J Pharm Biomed Anal 2006;41:1191–1197.
   PubMed Web of Science ®Google Scholar
• Perissutti B, Rubessa F, Moneghini M, Voinovich D. Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique. Int J Pharm 2003;256:53–63.
   PubMed Web of Science ®Google Scholar
• Verheyen S, Blaton N, Kinget R, Van den Mooter G. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm 2002;249:45–58.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Sunada H. Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems. Chem Pharm Bull (Tokyo) 1997;45:1688–1693.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Owen SC, editors. Handbook of pharmaceutical excipients. 5th ed. London: Pharmaceutical Press and American Pharmacists Association; 2006.
   Google Scholar
• Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS Pharm Sci Tech 2006;7:E55.
   PubMed Web of Science ®Google Scholar
• Okonogi S, Puttipipatkhachorn S. Dissolution improvement of high drug-loaded solid dispersion. AAPS Pharm Sci Tech 2006;7:E52.
   PubMedGoogle Scholar
• Sunada H, Bi Y. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol 2002;122:188–198.
   Web of Science ®Google Scholar
• Bae JW, Kim MJ, Jang CG, Lee SY. Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2007;859:69–73.
   PubMed Web of Science ®Google Scholar
• Craig DQM. Polyethylene glycols and drug release. Drug Dev Ind Pharm 1990;16:2501–2526.
   Web of Science ®Google Scholar
• Leonardi D, Barrera MG, Lamas MC, Salomon CJ. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters. AAPS Pharm Sci Tech 2007;8:E108.
   Google Scholar
• Beech DV, Booth C, Dodgson DV, sharpe RR, Warring JRS. Melting of low molecular weight poly(ethylene oxide). Polymer 1972;13:73–77.
   Web of Science ®Google Scholar
• Lloyd GR, Craig DQ, Smith A. A calorimetric investigation into the interaction between paracetamol and polyethlene glycol 4000 in physical mixes and solid dispersions. Eur J Pharm Biopharm 1999;48:59–65.
   PubMed Web of Science ®Google Scholar
• Najib NM, Suleiman MS. Characterization of a diflunisal polyethylene glycol solid dispersion system. Int J Pharm 1989;51:225–232.
   Web of Science ®Google Scholar
• Craig DQ. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002;231:131–144.
   PubMed Web of Science ®Google Scholar
• Sjökvist Saers E, Craig DQM. An investigation into the mechanisms of dissolution of alkyl p-aminobenzoates from polyethylene glycol solid dispersions. Int J Pharm 1982;83:211– 219.
   Google Scholar
• Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS Pharm Sci Tech 2004;5:e36.
   PubMed Web of Science ®Google Scholar
• Patel DM, Patel M. Optimization of fast dissolving etoricoxib tablets prepared by sublimation technique. Indian J Pharm Sci 2008;70:71–76.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Matsubara K, Koida Y, Kobayashi M. The preparation of rapidly disintegrating tablets in the mouth. Pharm Dev Technol 2001;6:487–493.
   PubMed Web of Science ®Google Scholar
• Ndindayino F, Henrist D, Kiekens F, Van den Mooter G, Vervaet C, Remon JP. Direct compression properties of melt-extruded isomalt. Int J Pharm 2002;235:149–157.
   PubMed Web of Science ®Google Scholar
• Ndindayino F, Henrist D, Kiekens F, Vervaet C, Remon JP. Characterization and evaluation of isomalt performance in direct compression. Int J Pharm 1999;189:113–124.
   PubMed Web of Science ®Google Scholar
• Bolhuis GK, Engelhart JJ, Eissens AC. Compaction properties of isomalt. Eur J Pharm Biopharm 2009;72:621–625.
   PubMed Web of Science ®Google Scholar
• Kottke MK, Rudnic EM. Modern pharmaceutics. 4th ed. Banker GS, Rhodes CT, editors. New York: Marcel Dekker Inc; 2002.
   Google Scholar
• Zhao N, Augsburger LL. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS Pharm Sci Tech 2005;6:E120–126.
   PubMed Web of Science ®Google Scholar
• Bi YX, Sunada H, Yonezawa Y, Danjo K. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm 1999;25:571–581.
   PubMed Web of Science ®Google Scholar
• Bi Y, Yonezawa Y, Sunada H. Rapidly disintegrating tablets prepared by the wet compression method: Mechanism and optimization. J Pharm Sci 1999;88:1004–1010.
   PubMed Web of Science ®Google Scholar
• Serajuddin AT. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88:1058–1066.
   PubMed Web of Science ®Google Scholar
• Koizumi K, Watanabe Y, Morita K, Utoguchi N, Matsurnoto M. New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int J Pharm 1997;152:127–131.
   Web of Science ®Google Scholar
• Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Sci 2002;15:295–305.
   PubMed Web of Science ®Google Scholar
• Chebli C, Cartilier L. Cross-linked cellulose as a tablet excipient: A binding/disintegrating agent. Int J Pharm 1998;171:101–110.
   Google Scholar
• Bolhuis GK, Rexwinkel EG, Zuurman K. Polyols as filler-binders for disintegrating tablets prepared by direct compaction. Drug Dev Ind Pharm 2009;35:671–677.
   PubMed Web of Science ®Google Scholar
• Kuno Y, Kojima M, Ando S, Nakagami H. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols. J Control Release 2005;105:16–22.
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Abdel-Salam HM, El-Sayad MA, Mekhel MM. Tablet formulation containing meloxicam and beta-cyclodextrin: Mechanical characterization and bioavailability evaluation. AAPS Pharm Sci Tech 2004;5:e59.
   PubMed Web of Science ®Google Scholar